Interleukin-1β Increases Baseline Expression and Secretion of Interleukin-6 by Human Uveal Melanocytes In Vitro via the p38 MAPK/NF-κB Pathway
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
PURPOSE: Melanocyte is the major cell component in the uvea. Interleukin (IL)-6 is a proinflammatory cytokine. The authors studied the expression of IL-6 in cultured human uveal melanocytes (UMs) and their modulation by IL-1β and explored the relevant signal pathways. METHODS: Conditioned media and cells were collected from UMs cultured in medium with and without serum and were stimulated by IL-1β. IL-6 protein and transcript were measured using an ELISA kit and RT-PCR, respectively. NF-κB in nuclear extracts and phosphorylated p38 MAPK, ERK, and JNK in cells cultured with and without IL-1β were measured by ELISA kits. Inhibitors of p38 (SB203580), ERK (UO1026), JNK (SP600125), and NF-κB (BAY11-7082) were added to the cultures to evaluate their effects. RESULTS: Low levels of IL-6 protein were detected in the conditioned medium in UMs cultured without serum. The addition of serum increased the secretion of IL-6. IL-1β (0.1-10 ng/mL) increased IL-6 transcript and protein levels in a dose- and time-dependent manner up to sixfold, accompanied by a significant increase of NF-κB in nuclear extracts and phosphorylated p38 MAPK in cell lysates. NF-κB and p38 inhibitors alone decreased, whereas a combination of these two inhibitors completely abolished the IL-1β-induced expression of IL-6. CONCLUSIONS: This is the first report on the expression and secretion of IL-6 by UMs. IL-1β augments IL-6 production from the melanocytes. The data suggest that UMs may play a role in the pathogenesis of ocular inflammatory and autoimmune diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Uveal melanocytes release MCP-1, IL-6 and IL-8 after an inflammatory stimulation by LPS or IL-1β that is accompanied by JNK1/2 upregulation and can also be attenuated by p38 inhibition [ 182 , 183 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [183]
Citations
Cites
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
The IL-1 family: regulators of immunity
Sims, J. E., & Smith, D. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2691 · Cited by 1,418
Nuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
IL-6 in autoimmune disease and chronic inflammatory proliferative disease
Ishihara, K., & Hirano, T. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00027-8 · Cited by 807
Interleukin 6 and its receptor: ten years later
Hirano, T. (1998) · International Reviews of Immunology · doi:10.3109/08830189809042997 · Cited by 788
Para-Inflammation in the Aging Retina
Xu, H., Chen, M., & Forrester, J. V. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.001 · Cited by 659
Self-citationInterleukin-1β and the Autoinflammatory Diseases
Dinarello, C. A. (2009) · New England Journal of Medicine · doi:10.1056/nejme0811014 · Cited by 226
Funk, M., Kriechbaum, K., Prager, F., Benesch, T., Georgopoulos, M., Zlabinger, G. J., & Schmidt-Erfurth, U. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2510 · Cited by 224
Tocilizumab: The first interleukin-6-receptor inhibitor
Sebba, A. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070449 · Cited by 214
Aqueous humor interleukin-6 levels in uveitis.
Murray, P. I., Hoekzema, R., Haren, M. A. C. V., de Hon, F. D., & Kijlstra, A. (1990) · PubMed · Cited by 190
Sugita, S., Takase, H., Taguchi, C., Imai, Y., Kamoi, K., Kawaguchi, T., Sugamoto, Y., Futagami, Y., Itoh, K., & Mochizuki, M. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1547 · Cited by 166
Immunopathological aspects of age-related macular degeneration
Patel, M., & Chan, C.-C. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0112-9 · Cited by 164
Self-citationRole of cytokines, acute-phase proteins, and chemokinesin the progression of rheumatoid arthritis
Badolato, R., & Oppenheim, J. J. (1996) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(96)80041-2 · Cited by 161
Simultaneous Analyses of Vitreous Levels of 27 Cytokines in Eyes with Retinopathy of Prematurity
Sato, T., Kusaka, S., Shimojo, H., & Fujikado, T. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.04.026 · Cited by 155
Cytokines and Chemokines in Uveitis - Is there a Correlation with Clinical Phenotype?
Ooi, K. G.-J., Galatowicz, G., Calder, V. L., & Lightman, S. L. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.4.294 · Cited by 152
Foxman, E. F., Zhang, M., Hurst, S. D., Muchamuel, T., Shen, D., Wawrousek, E. F., Chan, C.-C., & Gery, I. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2483 · Cited by 148
Self-citationWakamatsu, K., Hu, D., McCormick, S. A., & Ito, S. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2007.00415.x · Cited by 146
Self-citationPolarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells
Holtkamp, G. M., Van Rossem, M., DE Vos, A. F., Willekens, B., Peek, R., & Kijlstra, A. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00560.x · Cited by 146
Interleukin-6 in the pathogenesis of rheumatoid arthritis.
Park, J. Y., & Pillinger, M. H. (2007) · PubMed · Cited by 143
You, M., Flick, L. M., Yu, D., & Feng, G.-S. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.101 · Cited by 134
Possible Pathophysiological Roles of Mitogen‐Activated Protein Kinases (MAPKs) in Endometriosis
Yoshino, O., Osuga, Y., Hirota, Y., Koga, K., Hirata, T., Harada, M., Morimoto, C., Yano, T., Nishii, O., Tsutsumi, O., et al. (2004) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2004.00231.x · Cited by 133
Hu, D., McCormick, S. A., Ritch, R. H., & Pelton-Henrion, K. (1993) · PubMed · Cited by 129
Self-citationLeung, K. W., Barnstable, C. J., & Tombran‐Tink, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.12.001 · Cited by 127
Regulation of IL‐1‐induced selective IL‐6 release from human mast cells and inhibition by quercetin
Kandere‐Grzybowska, K., Kempuraj, D., Cao, J., Cetrulo, C. L., & Theoharides, T. C. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706695 · Cited by 115
van Kooij, B., Rothová, A., Rijkers, G. T., & de Groot-Mijnes, J. D. F. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.02.052 · Cited by 115
Canataroglu, H., Varinli, I., Ozcan, A. A., Canataroglu, A., Doran, F., & Varinli, S. (2005) · Ocular Immunology and Inflammation · doi:10.1080/09273940490518900 · Cited by 112
ROH, M. I., KIM, H. S., SONG, J. H., LIM, J. B., KOH, H. J., & KWON, O. W. (2009) · Retina · doi:10.1097/iae.0b013e318195cb15 · Cited by 109
Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1.
Planck, S. R., Dang, T. T., Graves, D. T., Tara, D., Ansel, J. C., & Rosenbaum, J. T. (1992) · PubMed · Cited by 108
Roh, M., Kim, H. S., Song, J. H., Lim, J., & Kwon, O. W. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.09.036 · Cited by 103
Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1.
Ferrick, M., Thurau, S. R., Oppenheim, M., Herbort, C., Ni, M., Zachariae, C. O. C., Matsushima, K., & Chan, C. (1991) · PubMed · Cited by 86
Self-citationNew insights into Vogt-Koyanagi-Harada disease
Damico, F. M., Bezerra, F. T., da Silva, G. C., Gasparin, F., & Yamamoto, J. H. (2009) · Arquivos Brasileiros de Oftalmologia · doi:10.1590/s0004-27492009000300028 · Cited by 76
Uveal Melanocytes, Ocular Pigment Epithelium, and Müller Cells in Culture: In Vitro Toxicology
Hu, D., Savage, H. E., & Roberts, J. E. (2002) · International Journal of Toxicology · doi:10.1080/10915810290169891 · Cited by 73
Self-citationExperimental Melanin—protein-induced Uveitis in the Lewis Rat
Chan, C., Hikita, N., Dastgheib, K., Whitcup, S. M., Gery, I., & Nussenblatt, R. B. (1994) · Ophthalmology · doi:10.1016/s0161-6420(94)31199-7 · Cited by 73
Self-citationWu, W., Hu, D., Gao, H.-X., Chen, M., Wang, D., Rosen, R. B., & McCormick, S. A. (2010) · PubMed Central · Cited by 72
Self-citationYoshino, O., Osuga, Y., Hirota, Y., Koga, K., Hirata, T., Yano, T., Ayabe, T., Tsutsumi, O., & Taketani, Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021788 · Cited by 68
Melanogenesis by human uveal melanocytes in vitro.
Hu, D., McCormick, S. A., Orlow, S. J., Rosemblat, S., Lin, A. Y., & Wo, K. (1995) · PubMed · Cited by 61
Self-citationNagineni, C. N., Detrick, B., & Hooks, J. J. (1994) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.1.5.569-577.1994 · Cited by 60
Regulation of Growth and Melanogenesis of Uveal Melanocytes
HU, D. (2000) · Pigment Cell Research · doi:10.1034/j.1600-0749.13.s8.15.x · Cited by 59
Self-citationMonocyte-induced cytokine expression in cultured human retinal pigment epithelial cells
Jaffe, G. J., Roberts, W. L., Wong, H. L., Yurochko, A. D., & Cianciolo, G. J. (1995) · Experimental Eye Research · doi:10.1016/s0014-4835(05)80068-5 · Cited by 55
Benson, M. T., Shepherd, L., Rees, R. C., & Rennie, I. G. (1992) · Current Eye Research · doi:10.3109/02713689208999529 · Cited by 49
Studies of human uveal melanocytes in vitro: growth regulation of cultured human uveal melanocytes.
Hu, D., McCormick, S. A., & Ritch, R. H. (1993) · PubMed · Cited by 36
Self-citationRegulation of Melanogenesis by Human Uveal Melanocytes in vitro
Hu, D., McCormick, S. A., Orlow, S. J., Rosemblat, S., & LIN, A. Y. (1997) · Experimental Eye Research · doi:10.1006/exer.1996.0223 · Cited by 34
Self-citationLü, F., Yan, D., Zhou, X., Hu, D., & Qu, J. (2007) · PubMed · Cited by 32
Self-citationHu, F., & Mah, K. (1979) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(79)90002-2 · Cited by 27
Maliner, M. S., Klein, R. D., Udayakumar, T. S., Nagle, R. B., & Bowden, G. T. (2001) · Neoplasia · doi:10.1038/sj.neo.7900178 · Cited by 25
Uveal Melanocytes Produce Matrix Metalloproteinases‐2 and ‐9 In Vitro
Chu, S., Hu, D., Yang, S., Yang, P., Hsieh, Y., Huang, S., Yu, G., & McCormick, S. A. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00181.x · Cited by 23
Self-citationExperimental Melanin-Induced Uveitis: Experimental Model of Human Acute Anterior Uveitis
Smith, J. R., Rosenbaum, J. T., & Williams, K. A. (2008) · Ophthalmic Research · doi:10.1159/000119864 · Cited by 19
Birkenkamp, K., Esselink, M., Kruijer, W., & Vellenga, E. (1999) · PubMed · Cited by 18
Tissue Plasminogen Activator is Released into Cultured Medium by Cultured Human Uveal Melanocytes
Wang, Y., Hu, D., McCormick, S. A., Savage, H. E., & O’Rourke, J. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02041.x · Cited by 17
Self-citationNakao, T., Kim, S., Ohta, K., Kawano, H., Hino, M., Miura, K., Tatsumi, N., & Iwao, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704797 · Cited by 14
Hu, D., & McCormick, S. A. (2003) · Informa Healthcare eBooks · doi:10.1201/9780203911136.ch9 · Cited by 9
Self-citation
Cited by
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“Uveal melanocytes release MCP-1, IL-6 and IL-8 after an inflammatory stimulation by LPS or IL-1β that is accompanied by JNK1/2 upregulation and can also be attenuated by p38 inhibition [182,183].”
BackgroundPeng, H., Sun, Y., Hao, J., Lu, C., Bi, M., & Song, E. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.11.006 · Cited by 45
Negm, O. H., Mannsperger, H., McDermott, E. M., Drewe, E., Powell, R. J., Todd, I., Fairclough, L. C., & Tighe, P. J. (2014) · European Journal of Immunology · doi:10.1002/eji.201344328 · Cited by 41
Human immunocompetent choroid-on-chip: a novel tool for studying ocular effects of biological drugs
Cipriano, M., Schlünder, K., Probst, C., Linke, K., Weiß, M., Fischer, M. J., Mesch, L., Achberger, K., Liebau, S., Mesquida, M., et al. (2022) · Communications Biology · doi:10.1038/s42003-021-02977-3 · Cited by 37
Hu, D.-N., Bi, M., Zhang, D. Y., Ye, F., McCormick, S. A., & Chan, C.-C. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-14685 · Cited by 36
“Activated NF-jB translocates to the nucleus and induces the expression of relevant genes, including various cytokines and chemokines.(10) It has been reported that LPS-induced expression of IL-8 and MCP-1 is through the activation and translocation of NF-jB to the nucleus.”
BackgroundSelf-citation
Metadata
- Authors
- Hu, D.-N., Chen, M., Zhang, D. Y., Ye, F., McCormick, S. A., & Chan, C.-C.
- Affiliations
- New York Medical College (US)
- From the Tissue Culture Center, Departments of Pathology and Ophthalmology, New York Eye and Ear Infirmary, New York Medical College, New York, New York;
- Icahn School of Medicine at Mount Sinai (US)
- National Institutes of Health (US)
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2011-05-31
- Volume
- 52
- Issue
- 6
- Pages
- 3767
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2059330078
- Cited by
- 33
- References
- 51
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 4 · 2012: 3
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- IL-1β, interleukin-6, uveal melanocytes, p38 MAPK, NF-κB signaling, cytokine production, uvea, ocular inflammation, autoimmune disease, MAPK inhibitors
- MeSH terms
- Cells, Cultured, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Humans, Melanocytes, Phosphorylation, RNA, Messenger, Uvea, Interleukin-6, NF-kappa B, Reverse Transcriptase Polymerase Chain Reaction, JNK Mitogen-Activated Protein Kinases, Extracellular Signal-Regulated MAP Kinases, p38 Mitogen-Activated Protein Kinases, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.